MyFinsight
Home
Blog
About
Contact
Download
Download image
Accounts receivable, net
$2,804K
Cash and cash
equivalents
$2,127K
Inventories, net
$1,555K
Prepaid expenses and
other current assets
$1,260K
Property and equipment,
gross
$469K
Investment in convertible
bond
$12,604K
Total current assets
$7,746K
Right of use assets
$766K
Other assets
$207K
Property and equipment,
net
$113K
Less accumulated
depreciation
$356K
Total assets
$21,436K
Accumulated deficit
-$270,067K
Net loan receivable
from ej holdings
$16,869K
Accumulated other
comprehensive loss
-$2,729K
Total liabilities and
stockholders' deficit
$21,436K
Total stockholders'
deficit
-$63,608K
Additional paid-in capital
$225,987K
Common stock, par value
0.001 per share,...
$70K
Total liabilities
$85,044K
Total current
liabilities
$69,072K
Other long-term
liabilities
$12,292K
Notes payable, less
current portion, net of...
$2,271K
Operating lease
liabilities, less current...
$1,409K
Accounts payable and
accrued expenses
$22,615K
Other current
liabilities
$17,565K
Convertible notes payable,
net of discount
$17,380K
Notes payable,
current portion, net of...
$8,019K
Notes payable,
current portion, net of...
$3,132K
Operating lease
liabilities, current portion
$348K
Warrant derivative
liabilities
$13K
Back
Back
Balance Sheet
source: myfinsight.com
Emmaus Life Sciences, Inc. (EMMA)
Emmaus Life Sciences, Inc. (EMMA)